Aztreonam-Avibactam Activity Against Gram-Negative Pneumonia Isolates
The following is a summary of “Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022),” published in the January...